Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-17

Clinical Trial Update: Additional Effect of Subthreshold Micropulse Laser to Intravitreous Injection of Bevacizumab on Diabetic Macular Edema [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial investigating the additional effect of subthreshold micropulse laser combined with intravitreal bevacizumab for diabetic macular edema, current…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bevacizumab (bevacizumab)

Snippet

Sponsor: Shahid Beheshti University of Medical Sciences | Conditions: Diabetic Macular Edema | Phase 2, Phase 3 | Status: UNKNOWN